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We have measured incorporation of the glucocorticoid hormone cortisone into nuclear hormone-receptor 
complexes in the C3H 10T’j2 cell line. As we had found cortisone to be capable of malignantly transforming 
these cells in vitrd, and certain protease inhibitors have been shown to suppress transfo~ation in this cell 
line, we investigated the effects of these protease inhibitors (antipain, chymostatin and the Bowman-Birk 
inhibitor) on the formation of nuclear cortisone-receptor complexes. All 3 inhibitors were found to suppress 
wholly or partially formation of nuclear cortisone-receptor complexes, suggesting that such complexes may 
be involved in the process of glucocorticoid-enhanced transformation. 
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1. INTRODUCTION 
Glucocorticoid hormones have been found to in- 
fluence carcinogenesis both in vivo [l-9] and in 
vitro [lO,ll]. Although a wide variety of ex- 
perimental conditions have been employed, the 
majority of results have reported suppressive ef- 
fects of glucocorticoids on tumorigenesis 
[2,4,8-lo], the extent of such suppression being 
roughly parallel to the anti-inflammatory strength 
of the hormones [4,8,9] as well as to their ability 
to inhibit DNA synthesis 191. The relatively weak 
gluc~orticoid cortisone, however, was found to 
exhibit little or no suppression of tumorigenesis in 
many of the above systems [2,4,8], and cortisone 
has been shown in other studies to increase 
chemically-induced tumor incidences in rodents in 
a co-carcinogenic or promotor-like manner 
[1,3,5-71. Our in vitro studies using the C3HIOT% 
cell line have found that cortisone both induces 
malignant transformation when added alone and 
enhances the yield of X-ray-induced transforma- 
tion [1 11. We found the potent glucocorticoid dex- 
amethasone, on the other hand, to be ineffective in 
transforming C3HlOT% cells either alone or in 
combination with X-irradiation [ 111. 
These studies were designed to investigate the 
processing of cortisone and dexamethasone by 
C3HlOT% cells through determination of whether 
these hormones are incorporated into nuclear 
hormone-receptor complexes, and whether any 
such incorporation is affected by the presence of 
certain protease inhibitors which have the ability to 
suppress carcinogen-induced malignant transfor- 
mation in C3HlOT% cells. Our studies on protease 
inhibitors as transformation-suppressing agents 
have been publish~ elsewhere [12,131. 
2. MATERIALS AND METHODS 
C3HlOTL/ cells were maintained at 37°C in a 
humidified atmosphere containing 5% CO2 in air, 
in Eagle’s basal medium (BME) supplemented with 
10% fetal calf serum and gentamycin (25 @g/ml). 
For binding experiments, cells were plated into 
150-mm dishes and grown to the monolayer stage. 
Cells were then scraped from the plates into BME 
using a rubber policeman, and dispersed by 
Published by Elsevier Science Publishers B. V. (Biomedical Divisron) 
00145793/85/$3.30 0 1985 Federation of European Biochemical Societies 27 
Volume 193, number 1 FEBS LETTERS November 1985 
repeated pipetting. Cell pellets were obtained by 
centrifugation and washed again .tith BME. The 
resulting cell pellets were dispersed in BME and in- 
cubated at 37°C with the desired radiolabelled hor- 
mone (lo-’ M [3H]cortisone, prepared through 
custom synthesis by New England Nuclear, 
28.6 Ci/mmol; 5 x 10e9 M [3H]dexamethasone, 
87.0 Ci/mmol, New England Nuclear). The pro- 
tease inhibitors antipain (Sigma), chymostatin 
(US-Japan Cooperative Cancer Research Pro- 
gram) and the Bowman-Birk inhibitor, prepared 
by us as described [12], were used at concentra- 
tions known to be effective in suppressing in vitro 
transformation [ 12,131, and were present during 
the full period of incubation with the hormone. 
Antipain was added at a concentration of 
50pg/ml, chymostatin at 0.5 or 10W6pg/ml and 
the Bowman-Birk inhibitor at 100 or 300 pg/ml. In 
experiments designed to measure protease in- 
hibitor effects on hormone binding following X- 
irradiation, cells were irradiated (400 rad) in the 
dishes immediately prior to scraping and subse- 
quent incubation as described above. Half the ir- 
radiated samples were incubated with cortisone 
alone, and half with cortisone supplemented with 
antipain (50 pg/ml). 
Following cellular incubation with hormone in 
the presence or absence of protease inhibitors, the 
incubation mixtures were diluted with 10 x 
volume of Earle’s balanced salt solution (EBSS) at 
4°C and centrifuged at 1000 x g for 5 min. (This 
and all subsequent steps were carried out at 4°C 
unless otherwise indicated.) The cell pellets were 
washed once with EBSS and the cells lysed through 
suspension in buffer A (10 mM Tris, pH 8; 0.1 M 
KCl; 0.5% Triton X-100; 20% (v/v) glycerol 
[14,15]). The lysis mixtures were centrifuged at 
1000 x g for 5 min, and the resulting nuclear 
pellets washed once with buffer B (10 mM Tris, 
pH 8; 0.1 M KCl; 20% (v/v) glycerol) and once 
with buffer C (10 mM Tris, pH 8; 1 mM CaC12; 
20% glycerol). The final nuclear pellets were 
dispersed in 1 ml buffer C and deposited on 
Gelman type A/E filters (25 mm) under suction. 
The incubation tubes were washed twice with 1 ml 
buffer C and the washings poured through the 
filters. 5 ml buffer C containing 1% Triton X-100 
and 7% ethanol were then deposited in each filter 
well and left on the filter for 5 min before being 
sucked through. The filters were then washed con- 
28 
tinuously with 20 ml buffer C containing 1% 
Triton X-100. These washing solutions have been 
shown to be effective in removing non-specifically 
bound nuclear steroid [16]. The filters were then 
air-dried, added to 10 ml toluene-based scintilla- 
tion fluid (Omnifluor, New England Nuclear) and 
counted (40% efficiency) in a Beckman LS-233 
scintillation counter. Following scintillation 
counting, the filters were removed from the 
counting vials, air-dried and nuclear DNA assayed 
by the diphenylamine reaction of Burton [17] as 
modified by Giles and Meyers [18], using calf 
thymus DNA as a standard. Levels of specifically 
bound hormone were calculated by subtracting 
binding in incubation mixtures containing excess 
added unlabelled hormone (non-specifically bound 
label) from binding in incubation mixtures con- 
taining labelled hormone only (non-specifically 
bound plus specifically bound label). 
3. RESULTS 
Table 1 presents levels of nuclear uptake of 
[3H]cortisone in C3HlOT% cells after an incuba- 
tion period of 1 h (found in preliminary ex- 
periments to yield maximum cortisone uptake, not 
shown). It can be seen that the protease inhibitors 
antipain and chymostatin (0.5 pg/ml) completely 
suppress cortisone binding, while the Bowman- 
Birk inhibitor reduces cortisone binding by ap- 
prox. 56%. A considerably lower concentration of 
chymostatin ( 1O-6 pg/ml, a concentration suffi- 
cient to inhibit radiation-induced transformation 
in C3H10TL/2 cells [13]), is ineffective in inhibiting 
nuclear cortisone binding. Irradiation of the cells 
followed by cortisone incubation in the presence or 
absence of antipain resulted in the elimination of 
hormone binding. In experiments conducted 
analogously to cortisone-binding experiments, 
neither antipain (50 ,ug/ml), chymostatin (50 
pg/ml), nor Bowman-Birk inhibitor (300 @g/ml) 
was found to affect nuclear uptake of [3H]dex- 
amethasone in C3HlOTM cells (J. Carew, 
unpublished). 
4. DISCUSSION 
These experiments were designed to investigate 
putative glucocorticoid binding to nuclei of 
C3HlOT% cells, and to ascertain whether any such 
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Table 1 
Effects of protease inhibitors and of pre-irradiation on 
nuclear binding of cortisone in C3HlOTti cells 
Treatment Binding (pmol cortisone/mg DNA) 
+ treatment - treatment 
Antipain 
(50 gg/ml) -0.014 -+ 0.015” 0.106 + 0.023 
Chymostatin 
(0.5 pg/ml) -0.027 + 0.030” 0.105 + 0.045 
Chymostatin 
( low6 pg/ml) 0.076 + 0.007 0.079 + 0.033 
Bowman-Birk 
inhibitor 
(100 fig/ml) 0.024 + 0.007 0.055 rfr 0.009 
Pre-irradiation 
(400 rad)b 0.002 f 0.021 -0.028 + 0.022a 
a Hormone binding values are obtained as the numerical 
difference of 2 independent measurements (binding 
levels in incubation mixtures containing labelled plus 
unlabelled hormone subtracted from binding levels in 
incubation mixtures containing labelled hormone only. 
See section 2). Thus a system in which zero binding is 
occurring may exhibit a mean of measurements falling 
on the negative as well as the positive side of zero. All 
‘negative’ means have been found by the Wilcoxen 
(Mann-Whitney) ranking test not to differ significantly 
from zero 
b The ’ + treatment’ value for 400 rad pre-irradiated 
cells arises from post-irradiation incubation of the cells 
with cortisone in the presence of antipain. The 
‘ - treatment’ value arises from post-irradiation 
incubation with cortisone alone 
Results represent the mean & SE of 8 separate 
determinations (antipain and Bowman-Birk inhibitor) 
and 4 separate determinations (chymostatin and antipain 
preceded by 400 rad irradiation). Treated and untreated 
samples were found to be statistically different (using 
Student’s f-test for independent samples) in the case of 
antipain (~~<0.001), chymostatin, 0.5 pg/ml @<0.05), 
Bowman-Birk inhibitor @<0.02). Other treatments 
were not found to affect binding in a statistically 
significant manner @> 0.05) 
binding is affected by the presence of protease in- 
hibitors. Protease inhibitors have been shown to 
suppress transformation induced by radiation 
W,131, chemicals [19,20], the sex hormone 
estradiol [21] and the glucocorticoid hormone cor- 
tisone ([l l] and unpublished). It was our intention 
to examine a common and much-studied feature of 
steroid hormone action, binding of hormone to a 
specific receptor protein, to determine whether 
such binding was exhibited by glucocorticoids in 
transformable C3H10T1/2 cells and whether any 
such binding was affected by protease inhibitors 
capable of suppressing glucocorticoid-induced 
transformation. Our results indicating that 3 pro- 
tease inhibitors inhibit formation of nuclear 
cortisone-receptor complexes suggest that hor- 
mone-receptor complex formation may play a role 
in cortisone-induced transformation. These results 
are consistent with our earlier finding that antipain 
both inhibited estradiol-induce transformation in 
C3H[lOT’/ cells 1211 and inhibited nuclear uptake 
of labelled estradiol in the MCF-7 breast tumor cell 
line [22], but this is the first report of protease in- 
hibitors suppressing nuclear steroidal uptake (table 
1) in a cell system in which they are also capable of 
suppressing steroidal-induced transformation. 
It is of interest hat antipain and ~hymostatin ex- 
hibit complete suppression of cortisone binding in 
this system, while the Bowman-Birk inhibitor ex- 
hibits partial suppression. This may be due to the 
relative sizes of these inhibitors. The smaller 
peptide-like substances antipain and chymostatin 
are likely to be capable of entering the cell and thus 
could directly perturb hormone-receptor binding 
events (such as the putative proteolysis of the 
native glucocorticoid receptor to convert it from 
large, non-steroid-binding forms to smaller forms 
capable of binding steroid [23,24], or direct recep- 
tor binding of steroid [25,26]). The considerably 
larger Bowman-Birk inhibitor is unlikely to 
penetrate the cell membrane [12] and thus may ex- 
ert its effect through a more remote, or indirect, 
mechanism. 
The effects of pre-irradiation in temporarily 
eliminating nuclear cortisone binding in the 
presence or absence of antipain (table 1) do not 
necessarily argue against a role for hormone- 
receptor complexes in cortisone-enhanced radia- 
tion transformation. In these experiments, cor- 
tisone was present for only 1 h post-irradiation 
while in previously reported tra~formation ex- 
periments the hormone was applied at frequent in- 
tervals and for an extended period post-irradiation 
[ 111, We have recently observed that cortisone has 
its enhancing/promotional effect on the transfor- 
29 
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mation process when given during the expression 
period of radiation transformation, or at long time 
periods post-irradiation [27]. Further experiments 
involving measurement of cortisone-receptor 
binding Ievels following repeated applications of 
the hormone post-irradiation will be necessary to 
test whether the hormone-receptor complex may 
be involved in the hormone enhancement of 
radiation-induced transformation. 
In summary, the results presented here are com- 
patible with a role for the cortisone-receptor com- 
plex in cortisone-induced transformation of 
C3HIOT% cells [II]. The mechanism through 
which glu~o~orti~oid-receptor complexes could 
contribute to the transformation process is not yet 
clear, and must await a more thorough 
characterization of molecular events resulting 
from glucocorticoid activity in this cell system. 
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